ACTION_TYPE valid names

ACTION_TYPEDESCRIPTIONPARENT_TYPE

ACTIVATOR

Positively effects the normal functioning of the protein e.g., activation of an enzyme or cleaving a clotting protein precursor

POSITIVE MODULATOR

AGONIST

Binds to and activates a receptor, often mimicking the effect of the endogenous ligand

POSITIVE MODULATOR

ALLOSTERIC ANTAGONIST

Binds to a receptor at an allosteric site and prevents activation by a positive allosteric modulator at that site

NEGATIVE MODULATOR

ANTAGONIST

Binds to a receptor and prevents activation by an agonist through competing for the binding site

NEGATIVE MODULATOR

ANTISENSE INHIBITOR

Prevents translation of a complementary mRNA sequence through binding and targeting it for degradation

NEGATIVE MODULATOR

BINDING AGENT

Binds to a substance such as a cell surface antigen, targetting a drug to that location, but not necessarily affecting the functioning of the substance itself

OTHER

BLOCKER

Negatively effects the normal functioning of an ion channel e.g., prevents or reduces transport of ions through the channel

NEGATIVE MODULATOR

CHELATING AGENT

Binds to a metal, reducing its availability for further interactions

OTHER

CROSS-LINKING AGENT

Induces cross-linking of proteins or nucleic acids

OTHER

DEGRADER

Binds to or antagonizes a receptor, leading to its degradation

NEGATIVE MODULATOR

DISRUPTING AGENT

Destabilises or disrupts a protein complex, macromolecular assembly, cell membrane etc

OTHER

EXOGENOUS PROTEIN

Protein from an exogenous source acts as a substitute or supplement for a specific protein which is absent or has reduced function in affected patients'

POSITIVE MODULATOR

HYDROLYTIC ENZYME

Hydrolyses a substrate through enzymatic reaction

OTHER

INHIBITOR

Negatively effects (inhibits) the normal functioning of the protein e.g., prevention of enzymatic reaction or activation of downstream pathway

NEGATIVE MODULATOR

INVERSE AGONIST

Binds to and inactivates a receptor

NEGATIVE MODULATOR

METHYLATING AGENT

Methylates or participates in methylation (e.g., through donation of a methyl group) of a substrate molecule

OTHER

MODULATOR

Effects the normal functioning of a protein in some way e.g., mixed agonist/antagonist or unclear whether action is positive or negative

OTHER

NEGATIVE ALLOSTERIC MODULATOR

Reduces or prevents the action of the endogenous ligand of a receptor through binding to a site distinct from that ligand (non-competitive inhibition)

NEGATIVE MODULATOR

NEGATIVE MODULATOR

Negatively effects the normal functioning of a protein e.g., receptor antagonist, inverse agonist or negative allosteric modulator

NEGATIVE MODULATOR

OPENER

Positively effects the normal functioning of an ion channel e.g., facilitates transport of ions through the channel

POSITIVE MODULATOR

OTHER

Other action type, not clearly postively or negatively affecting the normal functioning of a protein e.g., chelation of substances, hydrolysis of substrate

OTHER

OXIDATIVE ENZYME

Oxidises a substrate through enzymatic reaction

OTHER

PARTIAL AGONIST

Binds to and only partially activates a receptor (relative to the response to a full agonist)

POSITIVE MODULATOR

POSITIVE ALLOSTERIC MODULATOR

Enhances the action of the endogenous ligand of a receptor through binding to a site distinct from that ligand

POSITIVE MODULATOR

POSITIVE MODULATOR

Positively effects the normal functioning of a protein e.g., receptor agonist, positive allosteric modulator, ion channel activator

POSITIVE MODULATOR

PROTEOLYTIC ENZYME

Hydrolyses a protein substrate through enzymatic reaction

OTHER

REDUCING AGENT

Modifies a substrate via a reduction reaction

OTHER

RELEASING AGENT

Reverses the normal functioning of a transporter, causing release of the substrate, rather than uptake

NEGATIVE MODULATOR

RNAI INHIBITOR

Prevents translation of mRNA through binding and targeting it for destruction (e.g., siRNA)

NEGATIVE MODULATOR

SEQUESTERING AGENT

Binds to a substance such as a drug, toxin or metabolite reducing its availability for further interactions

OTHER

STABILISER

Increases the conformational stability of a protein or complex

OTHER

SUBSTRATE

Carried by a transporter, possibly competing with the natural substrate for transport

OTHER

VACCINE ANTIGEN

Delivers an antigen and promotes an immune response against the antigen e.g. activating the immune system towards cancer-specific biomarkers

OTHER

Last updated